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The enzymes responsible for the synthesis of the peptidoglycan (PG) layer constitute
a fundamental target for a large group of antibiotics. The family of β-lactam antibiotics
inhibits the DD-transpeptidase (TPase) activity of the penicillin binding proteins (PBPs),
whereas its subgroup of carbapenems can also block the TPase activity of the LD-
TPases. D-Ala fluorescent probes, such as NADA, are incorporated into the PG
presumably by TPases in Escherichia coli and can be used to study conditions that
are required for their function. Of all LD-TPases of E. coli, only LdtD was able to
incorporate NADA during exponential growth. Overproduction of LdtD caused NADA
to be especially inserted at mid cell in the presence of LpoB-activated PBP1b and the
class C PBP5. Using the NADA assay, we could confirm that LpoB activates PBP1b at
mid cell and that CpoB regulates the activity of PBP1b in vivo. Overproduction of LdtD
was able to partly compensate for the inhibition of the cell division specific class B PBP3
by aztreonam. We showed that class A PBP1c and the class C PBP6b cooperated
with LdtD for NADA incorporation when PBP1b and PBP5 were absent, respectively.
Besides, we proved that LdtD is active at pH 7.0 whereas LdtE and LdtF are more
active in cells growing at pH 5.0 and they seem to cooperate synergistically. The NADA
assay proved to be a useful tool for the analysis of the in vivo activities of the proteins
involved in PG synthesis and our results provide additional evidence that the LD-TPases
are involved in PG maintenance at different conditions.
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INTRODUCTION
Peptidoglycan (PG) maintains the shape of bacterial cells and protects them against bursting
due to the osmotic pressure. In Gram-negative bacteria, the PG layer is sandwiched between the
cytoplasmic and outer membrane in the periplasm (Vollmer et al., 2008a). PG is linked to the
outer membrane by covalent linkage with Braun’s lipoprotein and by non-covalent interactions
with proteins such as OmpA (Magnet et al., 2008; Samsudin et al., 2017). The synthesis of PG starts
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in the cytoplasm with the formation of UDP-N-acetylmuramyl
(UDP-MurNAc)-pentapetide and UDP-N-acetylglucosamine
(UDP-GlcNAc) precursors (Vollmer et al., 2008a), and continues
at the cell membrane with the formation of lipid I and lipid
II [GlcNAc-β-(1,4)-MurNAc(pentapeptide)-pyrophosphoryl-
undecaprenol] (Rogers et al., 1980; Henrich et al., 2016). Lipid
II is flipped across the cytoplasmic membrane most likely
by MurJ (Ruiz, 2015), FtsW/RodA (Mohammadi et al., 2014;
Meeske et al., 2016), or both, although the mechanism is not
yet totally defined. Penicillin binding proteins (PBPs) use lipid
II to polymerize glycan chains through their glycosyltransferase
(GTase) activity (Goffin and Ghuysen, 1998; Sauvage et al.,
2008). These chains are then attached to the existing PG
layer by transpeptidases (TPases) forming peptide cross-links
(Vollmer and Born, 2010). Escherichia coli, transpeptidation
occurs mainly by the activity of PBPs with DD-TPase activity,
which carry out the formation of the peptide cross-link between
D-Ala4 and meso-DAP3 (4–3 or DD cross-link) (Vollmer and
Born, 2010). In E. coli, the C-terminal domain of both class
A PBPs (PBP1a, PBP1b, and PBP1c) and the class B PBPs
(PBP2 and PBP3) (Sauvage et al., 2008) have TPase activity.
PBP1a and PBP1b are involved in both cell elongation and
division (Bertsche et al., 2006), whereas the role of PBP1c is
likely to be involved in a PG repair mechanism (Budd et al.,
2004). PBP1a and PBP1b are the major bi-functional PBPs
and at least one of these proteins is essential for the survival
of the cells (Yousif et al., 1985). The enzymatic activity of
PBP1a and PBP1b is stimulated by direct interaction with
their cognate outer-membrane anchored lipoproteins LpoA
and LpoB, respectively (Paradis-Bleau et al., 2010; Typas
et al., 2010). Another regulatory protein, CpoB, specifically
modulates the stimulation of the TPase of PBP1b by LpoB
in vitro, and together with TolA couples PG synthesis with
outer-membrane constriction during cell division (Gray et al.,
2015).
Class B PBPs are predicted monofunctional, essential
DD-TPases involved in cell elongation (PBP2) or cell division
(PBP3) (Den Blaauwen et al., 2008). Class C PBPs perform
DD-carboxypeptidase (DD-CPase) activity, for hydrolysis of the
D-Ala4-D-Ala5 peptide bond of the peptide stems (PBP4, PBP4b,
PBP5, PBP6a, and PBP6b), and/or endopeptidase (EPase) activity
for the cleavage of the D-Ala4-meso-DAP3 bonds (PBP4, PBP7,
AmpH) (Baquero et al., 1996; Broome-Smith et al., 1998; Vollmer
and Holtje, 2004; Vega and Ayala, 2006; Vollmer et al., 2008b).
PBP5 is the major DD-CPase in E. coli and its deletion results
in aberrant cells and severe morphological defects that the
other DD-CPases cannot compensate (Nelson and Young, 2000).
Under acidic conditions, PBP6b is more active and stable in vitro
and becomes the major DD-CPase (Peters et al., 2016).
In E. coli, the majority of the crosslinked stem peptides of the
PG net are 4–3 cross-links, made by PBPs, but between 3 and
10% connect two meso-DAP3 residues (Glauner et al., 1988). This
3–3 cross-linking reaction is performed by LD-TPases. E. coli
has six LD-TPases: LdtA to LdtF that were previously ErfK (A),
YbiS (B), YcfS (C), YcbB (D), YnhG (E), and YafK (F) (Magnet
et al., 2007, 2008; Morè et al., unpublished). The first three
enzymes (LdtA–C) transfer the meso-DAP3 residue of PG stem
peptides to the C-terminal Lys of Braun’s lipoprotein (Magnet
et al., 2007), increasing the stability of the cell envelope, while
LdtD-LdtF install 3–3 cross-links (Magnet et al., 2008; Morè
et al., unpublished). Whether the redundant LD-TPases perform
differently under divergent pH or other biochemical conditions,
as it was observed for DD-CPases (Peters et al., 2016), remains
still unknown.
β-Lactams antibiotics inhibit the DD-TPase activity of PBPs
(Curtis et al., 1979; Kocaoglu and Carlson, 2015), although
the subgroup of the carbapenems can inactivate both DD- and
LD-TPases (Mainardi et al., 2007). In Enterococcus faecium, LD-
TPases are able to bypass DD-TPases, leading to high level of
resistance to β-lactam antibiotics (Mainardi et al., 2005). This
resistance mechanism was recently reproduced in E. coli, where
the expression of ldtD resulted in resistance to ampicillin after
fully bypassing the DD-TPase pathway (Hugonnet et al., 2016).
This resistance relied on the overproduction of LdtD, although
a functional GTase domain of PBP1b and the DD-CPase activity
of PBP5 were identified as required for growth in the presence of
ampicillin (Hugonnet et al., 2016).
When the TPase activity of PBPs is blocked by β-lactams,
GTases will continue to synthesize glycan chains that are not
properly cross-linked (Park, 1995; Bertsche et al., 2005; Born
et al., 2006; Banzhaf et al., 2012; Cho et al., 2014), and the
still active LD-TPases may be able to bypass the DD-TPases
(Hugonnet et al., 2016). Since ampicillin does not discriminate
between PBPs, we investigated whether LdtD would be able to
compensate for the specific activity of the essential cell division
TPase PBP3. Interestingly, inhibition of PBP3 by aztreonam with
simultaneous expression of ldtD resulted in a specific phenotype
with bulges at the division site, which are absent in aztreonam-
treated cells not overproducing LdtD, and reduced the level of
cells lysis in treated cells with an inactive PBP1b TPase domain.
This indicates that LdtD is able to compensate at least partly for
the decrease in 4–3 cross-links when both PBP1b TPase domain
and the essential PBP3 are blocked. To study the function of
LdtD, we used the fluorescent D-amino acid (FDAA) NADA
(Kuru et al., 2012) that can be incorporated in the bacterial PG
likely by the activity of LD-TPases (Kuru et al., 2017). Through
this method, we confirmed the role of LdtD and its partners in
the incorporation of NADA as well as the function of LpoB and
CpoB in regulating PBP1b activity in vivo. These findings would
validate LdtD as new antibiotic target and could encourage the
development of an assay that allows the identification of new
antibiotics.
MATERIALS AND METHODS
Strains and Reagents
Unless specified, all different compounds used for media
composition were purchased from Sigma-Aldrich. NBD-
amino-D-alanine (NADA) and HCC-amino-D-alanine (HADA)
were synthesized according to Kuru et al. (2012). A detailed
description of the strains is shown in Supplementary Table S1.
Wild-type (WT) E. coli BW25113 strain was described in
(Datsenko and Wanner, 2000). E. coli BW251131(ldtA, ldtB,
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ldtC, ldtD, ldtE, ldtF) (BW2511316LDT) was described in
Kuru et al. (2017). BW251131(ldtA, ldtB, ldtC, ldtD, ldtE,
ldtF, dacA) (BW2511316LDT1dacA) was constructed by P1
phage transduction of E. coli BW2551316LDT as described
in Thomason et al. (2014). Donor lysate was prepared from
strain ECK0625 (with the deletion of dacA) from the Keio
collection (Baba et al., 2006). Single colonies were picked
and checked by PCR for successful replacement of the
dacA gene by the kanamycin resistance cassette. Positive
transductants were transformed with pCP20 to remove
the kanamycin cassette as described in Cherepanov and
Wackernagel (1995). BW251131lpoA, BW251131lpoB,
BW251131mrcA, BW251131mrcB, and BW251131cpoB
were described in Gray et al. (2015). BW251131pbpC is
from the Keio collection (Baba et al., 2006). WT CS109
and CS1091dacA are described in Denome et al. (1999).
CS1091dacC and CS1091dacD are described in Potluri et al.
(2012).
Plasmid Construction
A detailed description of the plasmids is shown in
Supplementary Table S3. pJEH12(LdtD) (Hugonnet et al., 2016)
was used to construct plasmids expressing the other LD-TPase
genes. pGS121, pGS124, pAMS01(LdtE), and pAMS02(LdtF)
were designed as described (Morè et al., unpublished).
pAMS03(LdtA), pAMS04(LdtB), and pAMS05(LdtC) were
constructed using the Gibson assembly method (Gibson et al.,
2009) by cloning ldtA, ldtB, and ldtC into pJEH12(LdtD),
respectively. ldtA, ldtB, and ldtC genes were amplified from
E. coli LMC500 (Taschner et al., 1988) chromosomal DNA using
oligonucleotides AMS-GA7k-F/AMS-GA7k-R, AMS-GA7y-
F/AMS-GA7y-R, and AMS-GA7c-F/AMS-GA7c-R, respectively
(Supplementary Table S2). These oligonucleotides contain 24-nt
overlapping arms for the pJEH12(LdtD) plasmid, upstream
and downstream the ldtD gene. The plasmid pJEH12(LdtD)
was fully linearized, except for the ldtD cassette, by PCR
amplification using oligonucleotides AMS-GA7-F and AMS-
GA7-R that anneal upstream and downstream the ldtD cassette.
Amplified fragments were mixed and assembled by incubating
them for 1 h at 50◦C in Gibson assembly mix (Gibson et al.,
2009).
The plasmid pSAV057 (Alexeeva et al., 2010) was used as
control plasmid since it lacks a cassette for the expression
of proteins involved in PG synthesis. The plasmids pWA001
(Banzhaf et al., 2012), pUM1Bα (Meisel et al., 2003), and
pNM039 were used to express mCherry-PBP1a, PBP1b gene,
and mCherry-PBP1c, respectively. pNM039 was constructed by
cloning pbpC into pNM004 (Meiresonne et al., 2017). pbpC was
amplified from chromosomal DNA with primers nm182 and
nm183 containing restriction sites for NcoI and EcoRI, also used
to digest pNM004. Plasmid and insert were ligated by using a T4
DNA ligase (NEB, Ipswich, MA, United States). PBP1b mutant
variants were produced from pUM1BTG∗α (PBP1bE233Q,
inactive GTase; PBP1b GT∗), pUM1Bα∗ (PBP1bS510A, inactive
TPase; PBP1b TP∗), and pUM1BTG∗α∗ (PBP1bE233Q, S510A,
with inactive GTase and TPase; PBP1b GT∗TP∗) (Meisel et al.,
2003).
pNM009, pAM6a, and pAM6b (Meiresonne et al., 2017) were
used for the expression of the genes of PBP5, PBP6a, and PBP6b,
respectively.
Peptidoglycan Labeling
The incorporation of FDAAs enables the analysis of real-time
PG biosynthesis in growing cells, without causing any significant
effect on cell growth rate (Kuru et al., 2012). LD-TPases require
tetrapeptides as donor peptides, where the Ala residue at position
4 will be replaced by the FDAA. Here we chose the FDAA
NADA to study its incorporation presumably by LdtD in vivo.
Supplementary Table S4 indicates the different strains used for
PG labeling experiments. For all the experiments, cells were
grown in rich medium [Lysogeny Broth (LB) or Antibiotic Broth
(AB) (Sigma-Aldrich)] overnight at 37◦C. The day after, samples
were diluted 1:500 in pre-warmed growth medium and grown
at 37◦C until OD600 was equal to 0.25. Cells were then diluted
(1:10) and the expression of ldtD was induced with 50 µM IPTG
for two mass doubling times when the OD600 was 0.05. Cells
were collected by centrifugation and resuspended in 100 µL
pre-warmed LB or AB medium. NADA (0.5 mM) (Kuru et al.,
2012) was added to the culture for 2 min at 37◦C except for
experiments shown in Figure 1 in which NADA labeling was
for 20 min. Cells were fixed in 70% ethanol for 10 min to
prevent potential cell stress resulted from the washing steps.
Cells were collected by centrifugation (5,000 rpm, 5 min) and
washed three times with PBS pH 7.4 (137 mM NaCl, 2.7 mM
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) to remove the excess
dye. Cells were immobilized on 1% agarose (Koppelman et al.,
2004) and imaged with a Nikon Eclipse T1 microscope (Nikon
Plan Fluor × 100/1.30 Oil Ph3 DLL objective) coupled to a
CMOS camera (Hamamatsu Flash 4.0). Quantification of the
total signal of NADA per µm3 average cell volume (indicated as
total concentration) was performed using ImageJ with the plugin
ObjectJ software (Visher et al., 2015).
When antibiotics were added to the growth medium (1 µg/mL
aztreonam; 1 µg/mL cefsulodin), these were added after one
mass doubling time after the addition of IPTG to allow protein
production. BW25113 cells expressing or not ldtD were treated
with 1 µg/mL cefsulodin for 60 min (approximately two mass
doublings). BW25113, BW251131cpoB, or BW251131lpoB cells
expressing or not ldtD were treated with 1 µg/mL aztreonam
for 20 and 60 min, respectively. BW251131mrcB cells producing
PBP1b, PBP1b TP∗, PBP1b, GT∗, or PBP1b GT∗TP∗, alone or in
combination with LdtD, were treated with 1 µg/mL aztreonam
for 60 min. Then cells were labeled with 0.5 mM NADA for 2 min
following the labeling protocol described above.
Preparation of Lysate From Cells
Overexpressing LD-TPase Genes
at pH 5.0
BW2511316LDT was transformed with pJEH12(LdtD),
pAMS01(LdtE), pAMS02(LdtF), a control plasmid (pSAV057;
Alexeeva et al., 2010), or the combination of pJEH12(LdtD) and
pGS124(LdtF) or pAMS02(LdtF) and pGS121(LdtE). A single
transformant was used to inoculate 5 mL of AB (Sigma-Aldrich)
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FIGURE 1 | LdtD is the main LD-TPase incorporating NADA at neutral pH during exponential growth. (A) Phase contrast and corresponding fluorescence images of
cells of BW2511316LDT (control), BW2511316LDT expressing ldtA–F (from left to right), and BW25113 in the presence of 0.5 mM NADA. Cells were grown to
exponential phase in LB at 37◦C. ldtD expression was induced for two mass doubling times with 50 µM IPTG, and the NADA pulse was for 20 min. Scale bar, 2 µm.
(B) Quantification of the cellular concentration of incorporated NADA in the BW2511316LDT strain not expressing (control) (n = 345) or expressing ldtA (n = 390),
ldtB (n = 309), ldtC (n = 620), ldtD (n = 368), ldtE (n = 846), or ldtF (n = 423) and in BW25113 cells (n = 305). The values are mean ± SD of n number of cells.
overnight at 37◦C at pH 5.0. A 1:1000 dilution was performed in
fresh AB cultures (400 mL each, in duplicate) from the overnight
cultures. Samples were grown at 37◦C and expression of LD-
TPase genes was induced with 50 µM IPTG when the OD600
was 0.2. After reaching the late exponential phase (OD600 0.8),
samples were cooled in ice and harvested by centrifugation at
4◦C. The cell pellet was resuspended in 6 mL ice-cold water
and dropped slowly into 6 mL boiling 8% SDS water solution.
Samples were boiled for 1 h.
Analysis of Muropeptide Composition by
HPLC
Peptidoglycan was prepared from 300 mL of cell lysate and
the muropeptide composition was determined as described
(Glauner et al., 1988; Bui et al., 2009). The PG was digested
with cellosyl (gift from Hoechst, Frankfurt, Germany) and
the resulting muropeptides were reduced with few crystals of
sodium borohydride in 250 mM sodium borate buffer, pH 9.0.
The reduced muropeptides were separated by HPLC and the
muropeptide pattern was analyzed as described (Glauner et al.,
1988).
Protein Purification
For the purification of LdtD, E. coli LOBSTR-BL21(DE3)
(Kerafast) cells were transformed with pETMM82, a plasmid
encoding for LdtD carrying an N-terminal DsbC-His6-tag
followed by a TEV-protease cleavage site (Hugonnet et al., 2016),
and grown at 30◦C in 1 L of TB medium (Tartof and Hobbs,
1987) (supplemented with 5 mM MgCl2 and 5 mM MgSO4)
until OD600 0.3. LdtD overproduction was induced by adding
IPTG (Generon) to a final concentration of 0.5 mM. Cells were
incubated for 19 h at 16◦C and harvested by centrifugation for
15 min at 4,500 rpm and 14◦C. The resulting cell pellet was
resuspended in 60 mL buffer A (20 mM Tris pH 8.0, 1 M
NaCl, 10 mM imidazole) supplemented with 1 mM phenylmethyl
sulfonyl fluoride (Sigma-Aldrich), 1× protease inhibitor cocktail
(Sigma-Aldrich), and deoxyribonuclease I (Sigma-Aldrich).
Cells were broken by sonication and centrifuged for 1 h at
130,000 × g at 4◦C. The supernatant was recovered, mixed with
0.5 mL Ni-NTA Superflow (Qiagen) preequilibrated in buffer A
(supplemented with 10 mM imidazole), and incubated under
continuous gentle stirring at 4◦C. After 1.5 h another 0.5 mL
of Ni-NTA Superflow (Qiagen) was added and incubated for
1.5 h. The suspension was poured in a gravity flow column and
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washed two times with 20 column volumes (CV) buffer B (20 mM
Tris/HCl pH 7.0, 150 mM NaCl) supplemented with 20 mM
imidazole, 5 mM ATP, and 1 mM MgCl2 to remove tightly bound
chaperone proteins. After three more washing steps with 20 CV
of buffer B each (2× 40 mM imidazole, 1× 50 mM imidazole),
the protein was eluted with buffer B supplemented with 300 mM
imidazole and glycerol was added to the elution fractions to a
final concentration of 10%. The protein was dialyzed against
2 × 2 L dialysis buffer 1 (25 mM Tris pH 7.0, 300 mM NaCl,
10% glycerol) for 1 h each at 4◦C. The protein solution was
supplemented with 5 mM β-mercaptoethanol (Sigma-Aldrich),
10 U/mL TEV-protease (Promega), and dialyzed against 1 L of
dialysis buffer 2 (25 mM Tris pH 7.0, 300 mM NaCl, 5 mM
β-mercaptoethanol, and 10% glycerol) for 1 h and against an
additional 1 L overnight at 4◦C.
The sample was mixed with 1 mL of Ni-NTA-agarose
preequilibrated in dialysis buffer 2 containing 50 mM of
imidazole and incubated for 2–3 h at 4◦C under gentle stirring.
The suspension was poured in a gravity flow column and the
DsbC-His-tag-free protein present in the flow through was
further purified by size exclusion chromatography on a HiLoad
26/60 Supedex 200 (GE Healthcare) column using size exclusion
buffer (25 mM Tris/HCl pH 7.5, 300 mM NaCl, 10% glycerol) and
a flow rate of 1 mL/min. Purity was determined by SDS–PAGE
and combined fractions were concentrated and stored in aliquots
at−80◦C.
PBP1b-TP∗ was purified as described in Typas et al. (2010);
LpoB was purified as described in Egan et al. (2014); PBP5 was
purified as described in Peters et al. (2016).
HADA Incorporation Assay With
Muropeptides
Assays were carried out in a final volume of 50 µL containing
25 mM Tris/HCl pH 7.0, 100 mM NaCl, 10 mM MgCl2, 0.1%
Triton X-100, 200 µM HADA, 2 µM LdtD, and muropeptides
(∼100 µg) obtained by digesting PG from BW2511316LDT with
cellosyl. The sample was incubated at 37◦C overnight and the
reaction was stopped by boiling for 10 min. Muropeptides were
reduced and analyzed by HPLC as described (Glauner et al.,
1988).
HADA Incorporation Coupled to PG
Synthesis
Assays were carried out in a final volume of 50 µL containing
50 mM Tris–HCl pH 7.0, 175 mM NaCl, 10 mM MgCl2,
0.1% Triton X-100, 200 µM HADA, radioactively labeled lipid
II (10,000 dpm) (Bertsche et al., 2005), 15 µL of PG from
BW2511316LDT, 1 µM PBP5, 1 µM PBP1b-TP∗, 2 µM LpoB,
and 2 µM LdtD. The reaction mixture was incubated for 2 h
at 37◦C. The reaction was stopped by boiling the samples for
10 min.
Samples were centrifuged for 20 min, the supernatant
recovered, and adjusted to pH 4 with 20% phosphoric acid. HPLC
analysis was carried out as described (Bertsche et al., 2005).
Muropeptides were detected by online radioactivity detector and
absorbance at 205 nm.
RESULTS
LdtD Is Required to Incorporate NADA at
Neutral pH
DD- and LD-TPases have been proposed as the enzymes
responsible for incorporation of FDAAs at the fourth position of
the PG peptide stem in Gram-negative species (Kuru et al., 2015,
2017). We used the green FDAA NADA (Kuru et al., 2012) to
label the PG of WT BW25113 and a strain lacking all LD-TPases
BW2511316LDT (Kuru et al., 2017). After a 20 min labeling
pulse, the strain BW25113 was labeled but BW2511316LDT did
not show any PG labeling (Figures 1A,B) despite the presence
of DD-TPases in both strains, indicating that at least one of the
LD-TPases is involved in the incorporation of NADA under these
conditions.
To determine which LD-TPase is responsible for NADA
incorporation, BW2511316LDT was transformed with plasmids
expressing the different LD-TPase genes. After a 20-min pulse
with NADA, only cells expressing ldtD incorporated NADA
(Figure 1A). The total concentration of incorporated NADA was
calculated and summarized in Figure 1B.
In vitro Activity of LdtD for FDAA
Incorporation
We also observed that purified LdtD was able to incorporate
HADA, another FDAA (Kuru et al., 2012), into muropeptides
(Supplementary Figure S1). The decrease in TetraTri(3–3) in
the presence of HADA (comparing the top two chromatograms
in Supplementary Figure S1A) might be due to competition
between LD-TPase and FDAA exchange reactions. Incubating
LdtD with radioactive labeled lipid II, PG from BW2511316LDT,
PBP5, a TPase inactive PBP1bTP∗, and LpoB lead to the
incorporation of HADA in vitro (Supplementary Figure S1B),
confirming the cooperation observed in vivo between LdtD and
other cell division proteins.
Effect of pH on 3–3 Cross-Linking
Activity
We evaluated the incorporation of NADA in the PG of
BW2511316LDT cells expressing ldtD, ldtE, ldtF, ldtD+ldtF, or
ldtE+ldtF at both pH 5.0 and 7.0 to verify whether their LD-
TPase activity has a pH preference. BW2511316LDT did not
show NADA incorporation in the PG of cells grown at either pH
(Figures 2A,B). At pH 7.0, the signal of NADA incorporation
was restored only when ldtD was mildly overproduced, in either
the presence or absence of ldtF (Figure 2A). Co-expressing
ldtD and ldtF lead to a higher fluorescent signal (Figure 2B)
compared to the expression of ldtD alone. Expressing ldtE
alone or in combination with ldtF did not show NADA
incorporation in the PG of BW2511316LDT grown at pH 7.0
(Figure 2A).
At pH 5.0, NADA was incorporated in the PG of the
BW2511316LDT when LdtE and LdtF were overproduced
together (Figure 2A). Expressing ldtD alone or in combination
with ldtF did not show PG labeling at pH 5.0 (Figure 2A).
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FIGURE 2 | Incorporation of NADA is pH dependent. (A) Phase contrast and corresponding fluorescence images of BW2511316LDT cells not expressing (control)
or expressing ldtD, ldtE, ldtF, ldtD and ldtF, or ldtE and ldtF at pH 5.0 or 7.0, and labeled with NADA. Cells were grown to exponential phase in LB at 37◦C.
LD-TPase genes expression was induced for two mass doubling with 50 µM IPTG, and the NADA pulse was for 2 min. Scale bar, 2 µm. (B) Concentration of NADA
in cells of BW2511316LDT strain not expressing (control) (n = 1000 at pH 5; n = 1216 at pH 7) or expressing ldtD (n = 903 at pH 5.0; n = 1329 at pH 7.0), ldtE
(n = 768 at pH 5.0; n = 2116 at pH 7.0), ldtF (n = 331 at pH 5.0; n = 1335 at pH 7.0), ldtD and ldtF (n = 294 at pH 5; n = 518 at pH 7), or ldtE and ldtF (n = 444 at
pH 5.0; n = 530 at pH 7.0). The values are mean ± SD of n number of cells.
To confirm the pH preference of LdtE and LdtF observed
in vivo, we analyzed the muropeptide composition of the PG of
BW2511316LDT expressing ldtD, ldtE, and/or ldtF at pH 5.0.
As expected, BW2511316LDT did not contain muropeptides
with 3–3 cross-links (Figures 3A,C). The PG of BW2511316LDT
expressing ldtD did not show any 3–3 cross-links (Figures 3A,C)
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FIGURE 3 | LD-TPase-mediated formation of 3–3 cross-links in cells growing at acidic pH. (A) Muropeptide profiles of BW2511316LDT cells containing either no
plasmid, control plasmid pSAV057, or plasmid for expression of ldtD, ldtE, ldtF, ldtE and ldtF, or ldtD and ldtF, grown in the presence of 50 µM IPTG at pH 5.0.
(B) Structures of major muropeptides numbered in the top chromatogram in panel A. LD-TPase products are muropeptides containing 3–3 cross-links (No. 4–6),
tripeptides (peaks 1 and 5), and glycine at position 4 (Gly4, No. 2 and 4). G, N-acetylglucosamine; M(r), N-acetylmuramitol; L-Ala, L-alanine; D-Glu, D-glutamic acid;
D-Ala, D-alanine; meso-DAP, meso-diaminopimelic acid. (C) Relative amount (%) of muropeptides with 3–3 cross-links.
but the co-expression of ldtD and ldtF in cells growing at pH
5.0 showed a small portion of muropeptides with 3–3 cross-links
(Figures 3A,C).
LdtE appeared to be weakly active in cells growing at pH
5.0, where 1.02% of the muropeptides contained 3–3 cross-links
(Figures 3C). However, co-expression of ldtF with ldtE in cells
growing at pH 5.0 increased the content of muropeptides with
3–3 cross-links from 1.02 to 13.47% (Figure 3C). LdtE and LdtF
may cooperate with each other synergistically.
NADA Incorporation by LdtD and Class A
PBPs
The NADA incorporation activity of LdtD was evaluated after
deletion of a gene encoding a Class A PBP (PBP1a, PBP1b,
or PBP1c) or their regulators (LpoA, LpoB, or CpoB). NADA
incorporation was detected in the lateral wall and at mid-cell
in BW251131mrcA and in BW251131lpoA strains expressing
ldtD with similar intensity, whereas a slightly lower NADA
concentration was observed for BW251131pbpC cells expressing
ldtD (Figures 4A,B). BW251131mrcB expressing ldtD did
not incorporate NADA indicating that PBP1b is needed for
NADA incorporation by LdtD. Surprisingly, ldtD expression
in BW251131lpoB cells showed a clear labeling of the lateral
wall but the signal at mid-cell was lost or weak in comparison
with BW251131lpoA cells (Figures 4A,B). This suggests that
the mid-cell incorporation of NADA is due to the local
activation of PBP1b by LpoB. To confirm this, BW25113 cells
expressing ldtD were treated with 1 µg/mL cefsulodin, since this
antibiotic is specific for PBP1a and PBP1b (Curtis et al., 1979;
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FIGURE 4 | PBP1b is required for NADA incorporation by LdtD. (A) Phase contrast and corresponding fluorescence images of cells of BW25113, BW251131lpoA,
BW251131mrcA (encoding PBP1a), BW251131lpoB, BW251131mrcB (PBP1b), BW251131pbpC (PBP1c), and BW251131cpoB expressing ldtD and labeled
with 0.5 mM NADA. Scale bar, 2 µm. The right panel shows the fluorescence profiles per average cell (from 0 to 1000 AU) plotted against normalized cell length
(from 0 to 100%). n represents the number of cells analyzed. (B) Concentration of NADA fluorescence (fluorescence signal per µm3 average cell volume).
Quantification of the incorporated NADA in the WT strain, BW251131lpoA, BW251131mrcA, BW251131lpoB, BW251131mrcB, BW251131pbpC, and
BW251131cpoB strains expressing ldtD. The values are mean ± SD of n number of cells. n is indicated on the fluorescence profiles.
Sarkar et al., 2012; Kocaoglu and Carlson, 2015). NADA was
incorporated in the lateral wall but clear empty septa (non-
labeled) were observed (Supplementary Figure S3), confirming
that the inhibition of PBP1b affected the NADA-incorporation
activity of LdtD at mid-cell, as in the case of the BW251131lpoB
strain. The deletion of cpoB did not allow the incorporation of
NADA by LdtD (Figure 4A).
Because PBP1b was found to be needed for NADA
incorporation by LdtD, BW251131mrcB was co-transformed
with pJEH12(LdtD) and a plasmid expressing PBP1a, PBP1b,
or PBP1c genes to determine whether any of these GTases
could compensate for the absence of PBP1b. Surprisingly,
co-expression of LdtD and PBP1a or PBP1c restored the
signal of PG labeling, with no differences in total NADA
concentration, but with the lack of NADA incorporation at mid-
cell (Figures 5A,B). As expected, the co-expression of the genes
encoding PBP1b and LdtD restored the signal not only at the
lateral wall but also at mid-cell (Figure 5A), confirming that
PBP1b is required for NADA incorporation by LdtD, especially
at mid-cell.
NADA Incorporation Requires Class C
PBPs
To determine whether a DD-CPase is required for the
NADA incorporation activity of LdtD, CS1091dacA (lacking
Frontiers in Microbiology | www.frontiersin.org 8 September 2018 | Volume 9 | Article 2101
fmicb-09-02101 September 3, 2018 Time: 16:40 # 9
Montón Silva et al. LD-Transpeptidase Activity Assay in Escherichia coli
FIGURE 5 | Effect of plasmid-expressed genes encoding class A PBPs on NADA incorporation by LdtD. (A) Phase contrast and corresponding fluorescence images
of BW251131mrcB (without PBP1b) (control) expressing or not ldtD, mrcA, mrcB, pbpC, ldtD and mrcA, ldtD and mrcB, or ldtD and pbpC, labeled with a 0.5 mM
NADA pulse of 2 min. Scale bar, 2 µm. The right panel shows the average normalized fluorescence profiles (green) and diameter (purple) per cell (from 0.0 to 1.0)
plotted against normalized cell length (from 0 to 100%). n represents the number of cells analyzed. (B) Concentration is the NADA fluorescence (signal per µm3
average cell volume). Quantification of the incorporated NADA in cells of BW251131mrcB (control) or expressing ldtD, mrcA, mrcB, pbpC, ldtD and mrcA, ldtD and
mrcB, and ldtD and pbpC. The values are mean ± SD of n number of cells. n is indicated on the fluorescence profiles.
PBP5), CS1091dacC (PBP6a), and CS1091dacD (PBP6b)
overproducing LdtD were labeled with NADA. Deletion of
dacA did not enable LdtD to incorporate NADA in the
PG (Figure 6A), whereas the deletion of dacC and dacD
allowed the labeling of cells with NADA (Figures 6A,B). This
indicates that PBP5 is required for the incorporation of NADA
by LdtD.
BW2511316LDT1dacA was co-transformed with
pJEH12(LdtD) and a plasmid expressing the genes of PBP5,
PBP6a, or PBP6b to determine whether any of these DD-CPases
could complement for the absence of PBP5. As expected, the
combined expression of ldtD and dacA restored the signal of
NADA incorporation (Figure 6C). Interestingly, co-expression
of ldtD and the gene encoding PBP6b also complemented
for the absence of PBP5 (Figure 6C) yielding similar NADA
incorporation at mid-cell compared to the co-expression of
dacA and ldtD (Figures 6C,D). Co-expressing ldtD and the gene
encoding PBP6a did not allow for LdtD-mediated incorporation
of NADA (Figure 6C) meaning that PBP6a, unlike PBP6b, is not
able to compensate for the absence of PBP5.
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FIGURE 6 | Class C PBP activity is required for NADA incorporation by LdtD. (A) Phase contrast and fluorescence images of CS109, CS1091dacA (PBP5)
expressing ldtD, CS1091dacC (PBP6a) expressing ldtD, and CS1091dacD (PBP6b) expressing ldtD labeled with a 0.5 mM NADA pulse of 2 min. Scale bar, 2 µm.
The right panel shows the average fluorescence profiles (green) and diameter (purple) per cell (from 0.0 to 1.0) plotted against normalized cell length (from 0 to
100%). n represents the number of cells analyzed. (B) Total concentration is the NADA fluorescence (signal per µm3 average cell volume). Quantification of the
incorporated NADA in the CS109 strain, CS1091dacA expressing ldtD, CS1091dacC expressing ldtD, and CS1091dacD expressing ldtD. The values are
mean ± SD of n number of cells. (C) Phase contrast and fluorescence images of BW5113D6LDTDdacA cells not expressing (control) or expressing ldtD, dacA, ldtD
and dacA, dacC, ldtD, and dacC, dacD, or ldtD and dacD, labeled with 0.5 mM NADA. Scale bar, 2 µm. The right panel shows the average fluorescence profiles
(green) and diameter (purple) per cell (from 0.0 to 1.0) plotted against normalized cell length (from 0 to 100%). (D) Quantification of the total concentration of
incorporated NADA in the BW2511316LDT1dacA cells not expressing (control) or expressing ldtD, dacA, ldtD and dacA, dacC, ldtD, and dacC, dacD, or ldtD and
dacD. The values are mean ± SD of n number of cells.
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Effect of Aztreonam on Cells Expressing
ldtD
We wanted to determine whether the overproduced LdtD could
compensate for the block of the essential cell division class B
PBP3. We treated BW25113 cells expressing or not ldtD with
aztreonam for 20 and 60 min and then labeled them with NADA.
We observed NADA incorporation at the lateral wall and mid-
cell after the 20 min pulse (Figures 7A,B mid-panel). After
60 min, cells overexpressing ldtD showed bulges at the previous
division site (Figure 7B low-panel) while cells not expressing
ldtD grew as smooth filaments (Figure 7A low-panel), indicating
that the expression of ldtD is responsible for this bulging
phenotype. Moreover, NADA incorporation was detected at one-
fourth and three-fourth of the filaments (Figure 7B low-panel),
presumably at preseptal sites. Similar results were observed for
the BW251131lpoB cells expressing ldtD (Figures 7C,D mid-
and lower-panel). In contrast, the BW251131cpoB strain grown
in the presence of aztreonam showed smooth filaments and
NADA was not incorporated irrespective whether ldtD was
expressed or not (Figures 7E,F).
Because of the importance of PBP1b for the function of LdtD,
we repeated the treatment with 1 µg/mL aztreonam for 1 h in
BW251131mrcB cells either expressing genes encoding different
PBP1b variants (WT PBP1b, PBP1b GT∗, PBP1b TP∗, and PBP1b
GT∗TP∗) alone or co-expressed with ldtD. In the absence of ldtD
expression, cells readily lysed in all cases except for the expression
of the WT PBP1b gene, which led to filaments with bulges at
mid-cell (Supplementary Figure S4). A similar level of lysis was
observed when ldtD was co-expressed with the genes encoding
PBP1b GT∗ or PBP1b GT∗TP∗. Interestingly, the level of lysis
was considerably lower when ldtDwas co-expressed with the gene
encoding PBP1b TP∗ (Supplementary Figure S4).
DISCUSSION
pH Dependence for FDAAs Incorporation
by LdtD
Penicillin-insensitive LD-TPases were proposed to be responsible
for the incorporation of exogenous D-Met, other D-amino acids
(Tsuruoka et al., 1984; Pisabarro et al., 1985; Caparrós et al.,
1992) and FDAA probes, such as NADA or HADA (Kuru
et al., 2012) into the terminal position of tetrapeptide stems in
E. coli. Here we aimed to identify which of the six LD-TPases
of E. coli incorporates NADA. NADA was readily incorporated
into BW25113 cells but not those of a strain lacking all LD-
TPase genes (BW2511316LDT), indicating that at least one of
the LD-TPs is required for the PG labeling by LD-TPases. In the
background of the BW2511316LDT strain, NADA incorporation
was only visible when LdtD was overproduced from a plasmid
(Figure 1). Because cells were grown in exponential phase,
LdtD might be more active in exponentially growing cells,
or has a higher NADA-incorporation activity than the other
LD-TPases catalyzing 3–3 cross-links, LdtE and LdtF (Magnet
et al., 2008; Morè et al., unpublished). It cannot be excluded
that PBPs can incorporate NADA, which is then immediately
removed by DD-CPases. However, since NADA incorporation
was not observed in the BW2511316LDT1dacA, the main DD-
CPase PBP5 is not needed for the removal. We also observed
that LdtD was able to incorporate the FDAA HADA in vitro
(Supplementary Figure S1). From both in vivo and in vitro
studies, we can conclude that FDAAs are a suitable substrate for
LdtD.
A recent study found that PBP6b is more active at pH 5.0
(compared to pH 7.5), whereas PBP5 and PBP6a showed a lower
activity at acidic pH, both in the cell and with the purified
enzymes (Peters et al., 2016). Presumably, E. coli maintains sets of
PG enzymes to grow robustly at different growth conditions, such
as different pH values (Pazos et al., 2017). LdtD was not able to
incorporate NADA at pH 5.0, whereas LdtE seemed to be inactive
at pH 7.0 and weakly active at pH 5.0 (Figure 2). Nevertheless,
LdtE and LdtF were observed to be more active when they were
overproduced together at acidic pH (Figures 2, 3). They may
be active under acidifying condition such as fermentation while
LdtD would be active during respiratory growth at near neutral
pH. Why co-expression of both ldtE and ldtF, and not ldtD and
ldtF, improved the incorporation of NADA at pH 5.0 remains
still unclear but it suggests the possibility of a potential activation
system between these two LD-TPases.
PBP1b, LpoB, and CpoB Are Required for
Efficient Incorporation of NADA by LdtD
LdtD can work on old, pre-formed PG (Supplementary
Figure S1) but may also work on newly synthesized PG
in the context of an ampicillin resistant mutant strain of
E. coli (Hugonnet et al., 2016). Indeed, we found here that
the incorporation of NADA by overproduced LdtD requires
the presence of PBP1b and its regulators LpoB and CpoB
(Figure 4A). The absence of PBP1a, PBP1c, or LpoA did not affect
the NADA incorporation by LdtD, since we observed PG labeling
in the BW251131lpoA, BW251131mrcA, and BW251131pbpC
strains whether (Figure 4A) or not (Supplementary Figure S2)
ldtD was expressed. These data align well with previous work
showing that LdtD is functionally linked to PBP1b but not PBP1a
(Hugonnet et al., 2016). In the BW251131mrcB strain, PBP1a
and PBP1c did not compensate for the absence of PBP1b to
enable LdtD-mediated NADA incorporation, unless they were
overproduced from plasmid together with LdtD (Figure 5A). Co-
overproducing LdtD and PBP1a or PBP1c restored the signal of
incorporated NADA only in the lateral wall but not at mid-cell.
This finding supposes the first phenotype associated with PBP1c
activity. PBP1c might have a role in situations where extra GTase
activity is required, as previously hypothesized (Budd et al., 2004).
Expression of ldtD in BW251131lpoB affected incorporation
of NADA at mid-cell (Figure 4A), although the labeling at
the lateral wall was comparable to the BW251131lpoA strain
(Figures 4A,B). LpoB showed enhanced localization at mid-cell
(Typas et al., 2010) where it would activate both GTase and TPase
activities of PBP1b (Egan et al., 2014). Treating BW25113 cells
with cefsulodin, which specifically inhibits PBP1a and b (Curtis
et al., 1979; Sarkar et al., 2012; Kocaoglu and Carlson, 2015),
provided similar results to the deletion of lpoB. Together, these
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FIGURE 7 | ldtD expression in aztreonam-treated cells creates bulges at mid-cell. Phase contrast images, corresponding fluorescent images, and fluorescence
profiles per average cell (from 0 to 2000 AU) plotted against normalized cell length (from 0 to 100%). (A) BW25113, (B) BW25113 expressing ldtD,
(C) BW251131lpoB, (D) BW251131lpoB expressing ldtD, (E) BW251131cpoB, and (F) BW251131cpoB expressing ldtD. Upper panel, no antibiotic; middle
panel, 20 min incubation with 1 µg/mL aztreonam; lower panel, 60 min of incubation with 1 µg/mL aztreonam. PG was labeled with 0.5 mM NADA with a 2 min
labeling pulse after the 20 or 60 min incubation with aztreonam. Scale bar, 2 µm. Red triangles point to mid-cell bulges. n represents the number of cells analyzed.
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results suggest that the activation of PBP1b by LpoB is required
for incorporation of NADA at mid-cell by LdtD.
CpoB modulates the stimulation of the TPase activity of
PBP1b (Gray et al., 2015). Deletion of cpoB renders cells
more sensitive to cefsulodin, indicating that the TPase activity
of PBP1b strongly contributes to PG synthesis (Gray et al.,
2015). Consistent with the hyper TPase activity of PBP1b,
NADA was presumably not incorporated in a BW251131cpoB
strain expressing ldtD because of the lack of available substrate
(Figure 4A). The results confirm and extend the role of CpoB as
a regulator of the TPase activity of PBP1b in vivo.
PBP6b Can Complement the Absence of
PBP5 for LdtD Activity
Deletion of dacA, encoding the major DD-CPase PBP5,
did obstruct the incorporation of NADA into PG by LdtD
(Figure 6A). PBP5 hydrolyzes the D-Ala4-D-Ala5 bond of
pentapeptide stems (Hugonnet et al., 2016), which results in
the production of tetrapeptides, which are the substrate for LD-
TPases (Magnet et al., 2008). Deletion of dacC (encoding PBP6a)
and dacD (encoding PBP6b) allowed incorporation of NADA by
overproduced LdtD and no significant differences were found
between the two deletion strains (Figure 6). This was expected for
PBP6b considering that its gene is known to be hardly expressed
during exponential growth (Li et al., 2014; Peters et al., 2016), and
also for PBP6A for which no in vivo activity has been reported
(Meiresonne et al., 2017).
To evaluate the possible complementation for the absence
of PBP5, LdtD and one of the class C PBPs (PBP5, PBP6a, or
PBP6b) were co-overproduced in a strain lacking all LD-TPs and
PBP5 (BW2511316LDT1dacA). PBP5 is the major DD-CPase
in E. coli and the morphological defects associated with deletion
of the corresponding gene cannot be compensated by the other
class C PBPs present on the chromosome (Nelson and Young,
2000). However, our studies show that overproduction of PBP6b
provided sufficient DD-CPase activity in a1dacA background to
support LdtD-mediated incorporation of NADA.
Expressing ldtD Causes Bulges in Cells
Treated With Aztreonam
Recently, we proved that LdtD is able to bypass the DD-TPase
pathway in cells treated with ampicillin (Hugonnet et al., 2016).
We observed that NADA was strongly incorporated at mid-cell
and the resistant E. coli was able to divide, which suggested
the involvement of the essential cell division class B PBP3
TPase activity. We decided to evaluate whether overproducing
LdtD could compensate for the decrease of 4–3 cross-linking
derived from the inhibition of the DD-TPase activity of PBP3 by
aztreonam (Sykes and Bonner, 1985). These cells have complete
division machineries at potential division sites at least for two
mass doublings (Pogliano et al., 1997; van der Ploeg et al.,
2013). The filaments showed bulges at mid-cell after 60 min
aztreonam treatment (approximately two mass doublings) in WT
BW25113 cells expressing ldtD, indicating that the expression
of ldtD may be responsible for this phenotype. This phenotype
was also observed in ampicillin-resistant E. coli expressing ldtD
(Hugonnet et al., 2016). Interestingly, bulges were also present in
the BW251131lpoB strain overproducing ldtD (Figures 7C,D),
whereas with active PBP3 the BW251131lpoB strain did not
incorporate NADA at mid-cell (Figure 4A). Consequently, the
NADA incorporation in aztreonam-inhibited BW251131lpoB
cells likely corresponds to lateral wall synthesis, which would
support the notion that PBP1b is not necessarily part of
the divisome but can be active at its periphery (Cho et al.,
2016).
Why does the overexpression of ldtD in aztreonam treated
cells result in bulges? After PBP3 is inhibited by β-lactams the
division machinery remains assembled for at least two mass
doublings (Pogliano et al., 1997; van der Ploeg et al., 2013). The
cells synthesize only PG for elongation, switching between phases
of pre-septal PG synthesis and dispersed, lateral PG synthesis.
After blocking PBP3 with aztreonam, the incorporation of
lipid-II in the PG layer is regulated by PBP1b. Perhaps the
endogenous LdtD activity in E. coli is not enough to compensate
for the decrease in 4–3 cross-links and to incorporate GTase-
derived glycan chains into PG when the essential DD-TPase
PBP3 is blocked by aztreonam. However, overproduction of
LdtD results in extra 3–3 cross-links that may lead to an
improperly orientated septal PG synthesis and subsequent bulge
formation. The presence of bulges at mid-cell is common in
E. coli cells treated with other β-lactams, from low concentrations
of penicillin (Schwarz et al., 1969) to high concentrations of
ampicillin (Hugonnet et al., 2016).
We also evaluated the effect of expressing ldtD when the
essential DD-TPase PBP3 is blocked by aztreonam and an
inactive PBP1b is overproduced, since we have detected a
dependence of LdtD on PBP1b. The overproduction of WT
PBP1b is non-lethal for the cells in contrast to the production of
inactive forms of PBP1b that cause cells to lyse (Supplementary
Figure S4; Meisel et al., 2003). Overproducing LdtD with PBP1b
TP∗ compensates for the loss in 4–3 cross-links, preventing
and/or delaying cell lysis and lead to the observed survival
phenotype.
With this work, we provide additional information on the role
of LdtD in β-lactam-treated cells. These observations imply that
inhibition of LD-TPases is a possible option to keep β-lactam
resistance at bay.
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